Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Aug;18(4):372-5.
doi: 10.1089/mdr.2011.0207. Epub 2012 Feb 28.

A new approach for pyrazinamide susceptibility testing in Mycobacterium tuberculosis

Mirko Zimic  1 , Sebastian Loli, Robert H Gilman, Andrés Gutierrez, Patricia Fuentes, Milagros Cotrina, Daniela Kirwan, Patricia Sheen
Affiliations

A new approach for pyrazinamide susceptibility testing in Mycobacterium tuberculosis

Mirko Zimic et al. Microb Drug Resist. 2012 Aug.

Abstract

Background: Pyrazinamide (PZA) is an important drug in the treatment of tuberculosis. Microbiological methods of PZA susceptibility testing are controversial and have low reproducibility. After conversion of PZA into pyrazinoic acid (POA) by the bacterial pyrazinamidase enzyme, the drug is expelled from the bacteria by an efflux pump.

Objective: To evaluate the rate of POA extrusion from Mycobacterium tuberculosis as a parameter to detect PZA resistance.

Methods: The rate of POA extrusion and PZA susceptibility determined by BACTEC 460 were measured for 34 strains in a previous study. PZA resistance was modeled in a logistic regression with the pyrazinoic efflux rate.

Result: POA efflux rate predicted PZA resistance with 70.83%-92.85% sensitivity and 100% specificity compared with BACTEC 460.

Conclusion: POA efflux rate could be a useful tool for predicting PZA resistance in M. tuberculosis. Further exploration of this approach may lead to the development of new tools for diagnosing PZA resistance, which may be of public health importance.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Correlation between the pyrazinoic acid (POA) efflux rate estimated from a 48-hr culture, VPOA(48h) (0, 12, 24, 36, and 48 hr), and estimated from a 12-hr culture, VPOA(12h) (0, 12 hr).
FIG. 2.
FIG. 2.
Sensitivity and specificity that determine pyrazinamide resistance based on the POA efflux rate for different cutoffs of the predicted probability. (A) Prediction of Bactec resistance (% growth >11%) based on VPOA(12h); (B) prediction of Bactec resistance (% growth >11%) based on VPOA(48h); (C) prediction of Bactec resistance (% growth >20%) based on VPOA(12h); (D) prediction of Bactec resistance (% growth >20%) based on VPOA(48h).
See this image and copyright information in PMC

References

    1. Ando H. Mitarai S. Kondo Y. Suetake T. Sekiguchi J.I. Kato S. Mori T. Kirikae T. Pyrazinamide resistance in multidrug-resistant Mycobacterium tuberculosis isolates in Japan. Clin. Microbiol. Infect. 2010;16:1164–1168. - PubMed
    1. Campanerut P.A. Ghiraldi L.D. Spositto F.L. Sato D.N. Leite C.Q. Hirata M.H. Hirata R.D. Cardoso R.F. Rapid detection of resistance to pyrazinamide in Mycobacterium tuberculosis using the resazurin microtitre assay. J. Antimicrob. Chemother. 2011;66:1044–1046. - PubMed
    1. Cheng S.J. Thibert L. Sanchez T. Heifets L. Zhang Y. pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada. Antimicrob. Agents Chemother. 2000;44:528–532. - PMC - PubMed
    1. Corbett E.L. Watt C.J. Walker N. Maher D. Williams B.G. Raviglione M.C. Dye C. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch. Intern. Med. 2003;163:1009–1021. - PubMed
    1. Heifets L. Lindholm-Levy P. Pyrazinamide sterilizing activity in vitro against semidormant Mycobacterium tuberculosis bacterial populations. Am. Rev. Respir. Dis. 1992;145:1223–1225. - PubMed

Publication types

MeSH terms